Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (TOI) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to -$0.71.

  • Oncology Institute's EPS (Weighted Average and Diluted) rose 2222.22% to -$0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.14, marking a year-over-year increase of 2222.22%. This contributed to the annual value of -$0.71 for FY2024, which is 2282.61% up from last year.
  • Oncology Institute's EPS (Weighted Average and Diluted) amounted to -$0.71 in FY2024, which was up 2282.61% from -$0.92 recorded in FY2023.
  • Oncology Institute's 5-year EPS (Weighted Average and Diluted) high stood at -$0.16 for FY2021, and its period low was -$0.92 during FY2023.
  • Over the past 5 years, Oncology Institute's median EPS (Weighted Average and Diluted) value was -$0.24 (recorded in 2020), while the average stood at -$0.45.
  • As far as peak fluctuations go, Oncology Institute's EPS (Weighted Average and Diluted) soared by 3333.33% in 2021, and later plummeted by 33809.52% in 2023.
  • Oncology Institute's EPS (Weighted Average and Diluted) (Annual) stood at -$0.24 in 2020, then soared by 33.33% to -$0.16 in 2021, then tumbled by 31.25% to -$0.21 in 2022, then plummeted by 338.1% to -$0.92 in 2023, then rose by 22.83% to -$0.71 in 2024.
  • Its EPS (Weighted Average and Diluted) was -$0.71 in FY2024, compared to -$0.92 in FY2023 and -$0.21 in FY2022.